Before initiating oral combined oral contraceptive pills, which parameter is essential to assess?

Before initiating oral combined oral contraceptive pills, which parameter is essential to assess?

• A. Cholesterol Level
• B. Blood Pressure
• C. Pulmonary Function
• D. Hemoglobin

Answer: (B)

Assessing cardiovascular safety is the key before starting estrogen-containing birth control. The estrogen in combined oral contraceptives can raise the risk of blood clots and cardiovascular events, and uncontrolled high blood pressure amplifies that risk. Measuring blood pressure helps identify hypertension that would make estrogen-containing methods unsafe, or at least warrant choosing alternatives. If blood pressure is elevated or hypertensive, the clinician will consider different options such as progestin-only contraception or nonhormonal methods. Lipids, lung function, or hemoglobin don’t directly determine safety for initiating these pills, so they’re not the essential prestart parameter.

Assessing cardiovascular safety is the key before starting estrogen-containing birth control. The estrogen in combined oral contraceptives can raise the risk of blood clots and cardiovascular events, and uncontrolled high blood pressure amplifies that risk. Measuring blood pressure helps identify hypertension that would make estrogen-containing methods unsafe, or at least warrant choosing alternatives. If blood pressure is elevated or hypertensive, the clinician will consider different options such as progestin-only contraception or nonhormonal methods. Lipids, lung function, or hemoglobin don’t directly determine safety for initiating these pills, so they’re not the essential prestart parameter.